KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Other Non-Current Liabilities (2019 - 2025)

GoodRx Holdings' Other Non-Current Liabilities history spans 7 years, with the latest figure at $8.7 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 29.4% year-over-year to $8.7 million; the TTM value through Dec 2025 reached $8.7 million, up 29.4%, while the annual FY2025 figure was $8.7 million, 29.4% up from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $8.7 million at GoodRx Holdings, up from $7.6 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $9.6 million in Q2 2023 and bottomed at $4.7 million in Q1 2022.
  • The 5-year median for Other Non-Current Liabilities is $7.6 million (2022), against an average of $7.4 million.
  • The largest annual shift saw Other Non-Current Liabilities decreased 25.09% in 2022 before it surged 70.04% in 2023.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $5.4 million in 2021, then surged by 40.41% to $7.6 million in 2022, then grew by 8.2% to $8.2 million in 2023, then dropped by 17.39% to $6.8 million in 2024, then grew by 29.4% to $8.7 million in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Other Non-Current Liabilities are $8.7 million (Q4 2025), $7.6 million (Q3 2025), and $7.0 million (Q2 2025).